DELIVER aims to develop scientific, clinical and community engagement capabilities needed to conduct HIV remission research in geographic regions most impacted by the epidemic.
DELIVER brings together research sites across the U.S., Sub-Saharan Africa, Southeast Asia and South America to collaborate, share expertise and launch clinical cure research.
DELIVER Network
A Missing Piece
We’ve made significant progress in HIV prevention and treatment, but a cure is a missing piece that could truly transform global health and the lives of people living with HIV.
About DELIVER HIV Cure Studies
HIV is difficult to cure because the virus can lie dormant in human cells, establishing what’s called a “latent reservoir” that allows it to evade the human immune as well as medication, and to reactivate in the absence of antiretroviral therapy. Research has shown that the best hope for long-term HIV remission may be a combination approach using several interventions together to target the virus. The HIV cure studies launched under DELIVER are helping to evaluate these strategies. The current DELIVER studies are small, early-phase trials carefully monitored for safety and approved by multiple independent ethics and regulatory boards. Results will be used to inform future HIV cure studies.
Current Studies
 | 
|